Inhibitors | Comment | Organism | Structure |
---|---|---|---|
alpha-1 antitrypsin | AAT | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P24158 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood plasma | PR3 plasma concentrations are increased in patients with liver steatosis | Homo sapiens | - |
neutrophil | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
neutrophil serine protease | - |
Homo sapiens |
PR3 | - |
Homo sapiens |
proteinase 3 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | PR3 plasma concentrations are increased in patients with liver steatosis. PR3 concentration is upregulated in patients with type 2 diabetes when compared to lean and obese controls | up |
General Information | Comment | Organism |
---|---|---|
malfunction | ratios between neutrophil serine proteases and their natural inhibitor are altered in non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes when compared to healthy controls | Homo sapiens |
metabolism | increased proteinase 3 and neutrophil elastase (EC 3.4.21.37) plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes, potential role for the neutrophil serine proteases (NSPs), proteinase-3 (PR3) and neutrophil elastase (NE), in NAFLD as well as an imbalance between NSPs and their natural inhibitor alpha-1 antitrypsin (AAT). Circulating levels of NSPs associate with obesity-related metabolic disorders | Homo sapiens |
physiological function | the neutrophil serine protease proteinase-3 (PR3) is able to process interleukin-1beta to its bioactive form independently of caspase-1-NLRP3 inflammasome complex | Homo sapiens |